CROSS COUNTRY HEALTHCARE INC Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cross Country Healthcare Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Cross Country Healthcare Inc Costs and Expenses for the quarter ending June 30, 2024 was $359M, a 29% decline year-over-year.
  • Cross Country Healthcare Inc Costs and Expenses for the twelve months ending June 30, 2024 was $1.56B, a 30.6% decline year-over-year.
  • Cross Country Healthcare Inc annual Costs and Expenses for 2023 was $1.91B, a 24.7% decline from 2022.
  • Cross Country Healthcare Inc annual Costs and Expenses for 2022 was $2.53B, a 64.8% increase from 2021.
  • Cross Country Healthcare Inc annual Costs and Expenses for 2021 was $1.54B, a 81.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.56B $359M -$147M -29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.7B $376M -$203M -35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.91B $401M -$176M -30.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $2.08B $422M -$162M -27.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.25B $506M -$169M -25.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $2.41B $579M -$119M -17.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $2.53B $577M +$12M +2.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $2.52B $584M +$235M +67.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.29B $675M +$359M +114% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.93B $698M +$390M +126% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.54B $565M +$355M +169% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $1.18B $348M +$154M +79.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.03B $316M +$85.5M +37.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $943M $308M +$97.4M +46.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $846M $210M -$3.2M -1.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $849M $194M -$14.7M -7.05% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $864M $230M +$12.6M +5.79% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $851M $211M +$13M +6.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $838M $213M -$11.9M -5.28% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $850M $209M +$11M +5.56% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $839M $218M +$17.6M +8.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $821M $198M -$8.18M -3.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $829M $225M -$975K -0.43% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $830M $198M -$22M -10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $852M $200M -$2.63M -1.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $855M $206M +$1.72M +0.84% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $853M $226M -$278M -55.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $1.13B $220M +$14.5M +7.03% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $1.12B $203M +$131M +182% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $986M $204M +$158M +345% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $827M $504M +$316M +169% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $511M $206M +$16.8M +8.92% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $494M $71.9M -$116M -61.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $610M $45.9M -$136M -74.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $747M $187M -$9.52M -4.83% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-02
Q3 2015 $756M $189M +$1.64M +0.88% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $755M $188M +$63.8M +51.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $691M $182M +$62.7M +52.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $628M $197M +$80.7M +69.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 $548M $187M +$80M +74.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $468M $125M +$12.1M +10.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $455M $120M +$9.07M +8.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $446M $116M +$3.58M +3.18% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $443M $107M -$6.37M -5.61% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $449M $112M -$17.8M -13.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $467M $111M -$199K -0.18% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $467M $113M +$50.7M +81.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 $416M $114M -$13.5M -10.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $430M $130M +$6.79M +5.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $423M $111M -$10.3M -8.49% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $433M $62M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 $127M +$14.3M +12.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $123M +$8.96M +7.83% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $121M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $113M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $114M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.